Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited
CLMR number: CLMR (23)A/01 Date issued: 12th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection (Mawdsley-Brooks & Company Limited). Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed 200686 [...]
The post Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited appeared first on PSNC Website.
Recent Comments